Riskpilot← Back to searchSign inGet full accessAGDER ØRE-NESE-HALS AS
ASActiveOrg 913555694Barstølveien 34, 4636 Kristiansand SGeneral medical practice activities · NACE 8621Est. 20148 employees
Revenue 2025
NOK 5,9M
-2% vs 2024
EBITDA margin
16.6%
-33% vs 2024
Equity ratio
48.1%
Financial strength
Net profit 2025
NOK 747K
-31% vs 2024
| Revenue | NOK 5,9M | -2% |
| EBITDA | NOK 973K | -33% |
| Net profit | NOK 747K | -31% |
| Total assets | NOK 2,3M | -32% |
| Equity | NOK 1,1M | -5% |
| Employees | 8 | — |
Legal name
AGDER ØRE-NESE-HALS AS
Org number
913555694
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
29. april 2014
Share capital
NOK 30 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legetjenester, unntatt psykiatrisk legetjeneste. Drift av øre-, nese-, halsklinikk og andre aktiviteter som hører til denne virksomheten, samt deltagelse i andre virksomheter.
Address
Barstølveien 34, 4636 Kristiansand S
Phone
+4738123040
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 362 | 6 160 | 6 224 | 5 979 | 5 871 |
| Staff expenses | −3 107 | −2 701 | −3 211 | −3 229 | −3 347 |
| EBITDA | 1 941 | 2 120 | 1 781 | 1 447 | 973 |
| Depreciation & amort. | −135 | −114 | −97 | −97 | −56 |
| EBIT | 1 806 | 2 006 | 1 684 | 1 351 | 917 |
| Net financials | 23 | 22 | 32 | 49 | 55 |
| Profit before tax | 1 829 | 2 028 | 1 716 | 1 399 | 972 |
| Tax | 410 | 454 | 387 | 318 | 225 |
| Net profit | 1 419 | 1 574 | 1 328 | 1 082 | 747 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 494 | 4 029 | 3 826 | 3 325 | 2 262 |
| Equity | 1 458 | 1 532 | 1 360 | 1 142 | 1 089 |
| Long-term debt | 16 | 12 | 8 | 2 | 0 |
| Short-term debt | 1 020 | 2 485 | 2 458 | 2 181 | 1 172 |
| Total debt | 1 036 | 2 497 | 2 465 | 2 183 | 1 174 |
EBITDA margin
16.6%
This company
15.8%
Market median
+5% vs market
20212025
Equity ratio
48.1%
This company
38.2%
Market median
+26% vs market
20212025
Return on equity
68.6%
This company
18.4%
Market median
+273% vs market
20212025
Net profit margin
12.7%
This company
8.1%
Market median
+57% vs market
20212025
Asset turnover
2.59×
This company
1.12×
Market median
+131% vs market
20212025
Debt / equity
1.08×
This company
0.62×
Market median
-74% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EB Deputy Member | Deputy Member | 2014 |
IM Chief Executive Officer | Chief Executive Officer | 2014 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AGDER ØRE-NESE-HALS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Broers Damsgaard | Deputy Member | 0 companies |
| Inger Marie Broers Damsgaard | Chief Executive Officer | 0 companies |